Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-016916

Ocata Therapeutics, Inc. · OCAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 31, 2015
Accepted (ET)
Jan 4, 2016 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001140098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 31, 2015A1,250—A252,206IBy Trust
Common StockF3Dec 31, 2015J0$0.00A15,530IBy Trust
Common StockF4Dec 31, 2015J0$0.00A15,530IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$8.36Jan 4, 2016A5,000AJan 4, 2016Jan 4, 2026Common Stock5,0005,000D

Explanation of responses